95 related articles for article (PubMed ID: 27816954)
1. Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkers.
Camps J; Joven J
Clin Chem Lab Med; 2017 Mar; 55(4):501-506. PubMed ID: 27816954
[TBL] [Abstract][Full Text] [Related]
2. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease.
Rodríguez-Gallego E; Guirro M; Riera-Borrull M; Hernández-Aguilera A; Mariné-Casadó R; Fernández-Arroyo S; Beltrán-Debón R; Sabench F; Hernández M; del Castillo D; Menendez JA; Camps J; Ras R; Arola L; Joven J
Int J Obes (Lond); 2015 Feb; 39(2):279-87. PubMed ID: 24675715
[TBL] [Abstract][Full Text] [Related]
4. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
6. Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
Becker PP; Rau M; Schmitt J; Malsch C; Hammer C; Bantel H; Müllhaupt B; Geier A
PLoS One; 2015; 10(11):e0142661. PubMed ID: 26565986
[TBL] [Abstract][Full Text] [Related]
7. Tissue Inhibitors of Metalloproteinase-1 and 2 and Obesity Related Non-Alcoholic Fatty Liver Disease: Is There a Relationship.
Abdelaziz R; Elbasel M; Esmat S; Essam K; Abdelaaty S
Digestion; 2015; 92(3):130-7. PubMed ID: 26329758
[TBL] [Abstract][Full Text] [Related]
8. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.
Amacher DE
Biomarkers; 2014 Nov; 19(7):541-52. PubMed ID: 25189636
[TBL] [Abstract][Full Text] [Related]
9. PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.
Gao Q; Jia Y; Yang G; Zhang X; Boddu PC; Petersen B; Narsingam S; Zhu YJ; Thimmapaya B; Kanwar YS; Reddy JK
Am J Pathol; 2015 May; 185(5):1396-408. PubMed ID: 25773177
[TBL] [Abstract][Full Text] [Related]
10. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
Pallayova M; Taheri S
Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
[TBL] [Abstract][Full Text] [Related]
12. NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMPLICATIONS--ASSESSING THE POPULATION AT RISK. A SMALL SERIES REPORT AND LITERATURE REVIEW.
Livadariu R; Timofte D; Danilă R; Ionescu L; Diaconu C; Soroceanu P; Sângeap AM; Drug VL; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):346-52. PubMed ID: 26204635
[TBL] [Abstract][Full Text] [Related]
13. The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.
Tan Y; Liu X; Zhou K; He X; Lu C; He B; Niu X; Xiao C; Xu G; Bian Z; Zu X; Zhang G; Zhang W; Lu A
PLoS One; 2016; 11(2):e0149043. PubMed ID: 26890003
[TBL] [Abstract][Full Text] [Related]
14. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children.
Alkhouri N; Cikach F; Eng K; Moses J; Patel N; Yan C; Hanouneh I; Grove D; Lopez R; Dweik R
Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):82-7. PubMed ID: 24284369
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
[TBL] [Abstract][Full Text] [Related]
16. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
Castera L
Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
